This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
Future Horizons and Growth Strategies in the UK Therapeutic Drug Monitoring (TDM) Market 2015 is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
Complete report $35,500. DataPack (test volumes, sales forecasts, supplier shares) $19,500.This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new ...
October 2016 | $0 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. VPGMarketResearch.com's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. RationaleDuring the next five years, the UK ...
August 2016 | $0 | View Details >>
2017 Venezuela Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing-Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test volume and sales forecasts- Feature comparison of major analyzers- Profiles of market players and start-up firms developing innovative ...
January 2017 | $0 | View Details >>
Notes: Sales, means the sales volume of Miniature Valves Revenue, means the sales value of Miniature Valves This report studies sales (consumption) of Miniature Valves in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Parker ASCO SMC Clippard Mac Valves Fischer Process ...
February 2017 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research